Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Blood-brain Barrier00:49

The Blood-brain Barrier

52.4K
Overview
52.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Twisted-Driven Photoionization of Aligned Chiral Molecules: Signatures of Circular and Helical Dichroism.

The journal of physical chemistry. A·2026
Same author

Social rank modulates empathic pain via Galntl6<sup>+</sup> anterior cingulate cortex-nucleus accumbens core circuit.

Molecular psychiatry·2026
Same author

Esketamine-led opioid-free anaesthesia reduces postoperative pulmonary complications in bariatric surgery patients: a prospective randomized controlled trial.

BMC anesthesiology·2026
Same author

Extreme rainfall and anaemia among children under five in 46 low- and middle-income countries.

BMJ global health·2026
Same author

Cytoplasmic Fidgetin Induces Noncanonical Activation of β-Catenin to Support Cancer Progression.

Cancer research·2026
Same author

A novel and evolutionarily distinct flavoprotein monooxygenase drives skatole degradation in <i>Rhodococcus</i>.

Applied and environmental microbiology·2026
Same journal

Neural mechanisms of fear memory precision and generalization: from auditory cortex to amygdala.

Translational psychiatry·2026
Same journal

Maraviroc attenuates inflammation-exacerbated cognitive and amyloid pathology in an early-stage Alzheimer's disease mouse model.

Translational psychiatry·2026
Same journal

High-order brain interactions during ketamine-induced state changes: A functional marker of response in late-life treatment-resistant depression?

Translational psychiatry·2026
Same journal

Immune-metabolic mediation of depression risk: Causal evidence from antibody and metabolite GWAS.

Translational psychiatry·2026
Same journal

DRD1 and DRD2 dopamine-sensitive neurons in the central amygdala respond differently to rewarding and aversive stimuli.

Translational psychiatry·2026
Same journal

Neuroinflammation and depression: immune-brain interface mechanisms, biomarker stratification, and therapeutic strategies.

Translational psychiatry·2026
See all related articles

Related Experiment Video

Updated: Jan 18, 2026

Author Spotlight: Advancing the Study of Brain-Heart Interplay with a Comprehensive EEGLAB Plugin for Multimodal Signal Analysis
08:22

Author Spotlight: Advancing the Study of Brain-Heart Interplay with a Comprehensive EEGLAB Plugin for Multimodal Signal Analysis

Published on: April 26, 2024

3.0K

CD38 connects the heart and brain.

Yijing Tao1,2, Jiahao Duan1, Kai Huang1

  • 1Department of Cardiology, The Third Affiliated Hospital of Soochow University, Changzhou, 213003, China.

Translational Psychiatry
|September 11, 2025
PubMed
Summary
This summary is machine-generated.

Cluster of differentiation 38 (CD38) plays a key role in heart and brain functions. Inhibiting CD38 may offer protection against cardiovascular diseases and neurological disorders.

More Related Videos

In Situ Detection of Autoreactive CD4 T Cells in Brain and Heart Using Major Histocompatibility Complex Class II Dextramers
13:10

In Situ Detection of Autoreactive CD4 T Cells in Brain and Heart Using Major Histocompatibility Complex Class II Dextramers

Published on: August 1, 2014

12.3K
Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model
06:19

Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model

Published on: October 20, 2023

2.8K

Related Experiment Videos

Last Updated: Jan 18, 2026

Author Spotlight: Advancing the Study of Brain-Heart Interplay with a Comprehensive EEGLAB Plugin for Multimodal Signal Analysis
08:22

Author Spotlight: Advancing the Study of Brain-Heart Interplay with a Comprehensive EEGLAB Plugin for Multimodal Signal Analysis

Published on: April 26, 2024

3.0K
In Situ Detection of Autoreactive CD4 T Cells in Brain and Heart Using Major Histocompatibility Complex Class II Dextramers
13:10

In Situ Detection of Autoreactive CD4 T Cells in Brain and Heart Using Major Histocompatibility Complex Class II Dextramers

Published on: August 1, 2014

12.3K
Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model
06:19

Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model

Published on: October 20, 2023

2.8K

Area of Science:

  • Biochemistry
  • Cardiology
  • Neurology

Background:

  • Cluster of differentiation 38 (CD38) is a transmembrane glycoprotein with significant roles in cardiac and neural tissues.
  • CD38 influences key cellular processes including calcium signaling, NAD+ metabolism, oxidative stress, and immune responses.

Purpose of the Study:

  • To review the expression patterns, regulatory mechanisms, and signaling pathways of CD38 in the heart and brain.
  • To explore the implications of CD38 in coexisting cardiovascular and neurological diseases.

Main Methods:

  • Literature review of studies on CD38 expression and function.
  • Analysis of CD38's role in cardiovascular and neurological disease pathogenesis.

Main Results:

  • CD38 exhibits diverse biological activities, including NADase and cyclase functions, impacting heart and brain health.
  • CD38 is involved in pathways linked to cardiovascular diseases (CVD) and neurological disorders.

Conclusions:

  • CD38 is implicated in the shared pathogenesis of heart-brain diseases.
  • Targeting CD38 presents a potential therapeutic strategy for managing combined cardiovascular and neurological conditions.